Table 1.
Characteristic | n (%) |
---|---|
Age at time of surgery | 59 (26–90)a |
<40 years | 10 (7.7) |
40–59 years | 62 (47.7) |
60–79 years | 44 (33.8) |
>79 years | 14 (10.8) |
Tumor localization | |
Unilateral—left | 60 (46.2) |
Unilateral— right | 64 (49.2) |
Bilateral | 6 (4.6) |
FIGO stage | |
Ia | 73 (56.2) |
Ib | 2 (1.5) |
Ic | 53 (40.8) |
IIa | 2 (1.5) |
Frozen section results | |
Not performed | 42 (32.3) |
Benign | 5 (3.8) |
Borderline | 9 (6.9) |
At least borderline | 15 (11.5) |
Malignant | 58 (44.6) |
Other | 1 (0.8) |
Histologic cell type | |
Mucinous | 35 (26.9) |
Papillary | 2 (1.5) |
Serous | 16 (12.3) |
Papillary mucinous | 1 (0.8) |
Serous papillary | 25 (19.2) |
Endometrioid | 30 (23.1) |
Clear-cell | 16 (12.3) |
Malignant Brenner tumor | 1 (0.8) |
Undifferentiated carcinoma | 2 (1.5) |
Adenocarcinoma (not specified further) | 2 (1.5) |
Tumor grade | |
I | 54 (41.5) |
II | 41 (31.5) |
III | 19 (14.6) |
Unknown | 16 (12.3) |
Attendance of gynecologic oncologist | |
No | 81 (68.6) |
Yes | 22 (18.6) |
Gynecologic oncologist (LUMC) | 15 (12.7) |
Surgical staging performance | |
Adequate | 56 (43.1) |
Inadequate | 62 (47.7) |
Surgical staging not purposed | 12 (9.2) |
Treatment according to protocol | |
Yes | 75 (57.7) |
No | 55 (42.3) |
Numbers indicate median (range).
EOC, early ovarian cancer; FIGO, International Federation of Gynecologic Oncologists; LUMC, Leiden University Medical Center.